Ausgabe 7/2009
Inhalt (8 Artikel)
Review
Indacaterol, a novel inhaled, once-daily, long-acting beta2-agonist for the treatment of obstructive airways diseases
Kai M. Beeh, Jutta Beier
Review
Aliskiren, the first approved renin inhibitor: Clinical application and safety in the treatment of hypertension
Graziano Riccioni, Nicola Vitulano, Nicolantonio D’Orazio, Fulvio Bellocci
Review
Dyslipidemia therapy update: the importance of full lipid profile assessment
I. B. A. Menown, G. Murtagh, V. Maher, M. T. Cooney, I. M. Graham, G. Tomkin
Original Research
Therapeutic effect of 1,5-pentanediol for herpes simplex labialis: a randomized, double-blind, placebo-controlled clinical trial
Regina Busch, Hans-Joachim Graubaum, Joerg Gruenwald, Jan Faergemann
Original Research
Comparing hydrocortisone and methylprednisolone in patients with septic shock
Teng-Jen Yu, Yu-Chih Liu, Chung-Chieh Yu, Jo-Chi Tseng, Chung-Ching Hua, Huang-Pin Wu
Erratum
Erratum to: Saxagliptin: a New DPP-4 inhibitor for the treatment of type 2 diabetes mellitus
Abd A. Tahrani, Milan K. Piya, Anthony H. Barnett
Erratum
Erratum to: Cost-effectiveness of transcranial magnetic stimulation in the treatment of major depression: a health economics analysis
Kit N. Simpson, Mary Jane Welch, F. Andrew Kozel, Mark A. Demitrack, Ziad Nahas